Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG).
Coghill D, Banaschewski T, Cortese S, Asherson P, Brandeis D, Buitelaar J, Daley D, Danckaerts M, Dittmann RW, Doepfner M, Ferrin M, Hollis C, Holtmann M, Paramala S, Sonuga-Barke E, Soutullo C, Steinhausen HC, Van der Oord S, Wong ICK, Zuddas A, Simonoff E. Coghill D, et al. Among authors: dittmann rw. Eur Child Adolesc Psychiatry. 2023 Aug;32(8):1337-1361. doi: 10.1007/s00787-021-01871-x. Epub 2021 Oct 22. Eur Child Adolesc Psychiatry. 2023. PMID: 34677682 Free PMC article. Review.
Non-stimulant medications in the treatment of ADHD.
Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Banaschewski T, et al. Among authors: dittmann rw. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I102-16. doi: 10.1007/s00787-004-1010-x. Eur Child Adolesc Psychiatry. 2004. PMID: 15322961 Review.
European guidelines on managing adverse effects of medication for ADHD.
Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E; European Guidelines Group. Graham J, et al. Among authors: dittmann rw. Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3. Eur Child Adolesc Psychiatry. 2011. PMID: 21042924 Free PMC article.
Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device.
Wehmeier PM, Schacht A, Wolff C, Otto WR, Dittmann RW, Banaschewski T. Wehmeier PM, et al. Among authors: dittmann rw. J Child Adolesc Psychopharmacol. 2011 Oct;21(5):433-44. doi: 10.1089/cap.2010.0142. J Child Adolesc Psychopharmacol. 2011. PMID: 22040189 Clinical Trial.
Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology.
Wehmeier PM, Schacht A, Ulberstad F, Lehmann M, Schneider-Fresenius C, Lehmkuhl G, Dittmann RW, Banaschewski T. Wehmeier PM, et al. Among authors: dittmann rw. J Clin Psychopharmacol. 2012 Oct;32(5):653-60. doi: 10.1097/JCP.0b013e318267c304. J Clin Psychopharmacol. 2012. PMID: 22926599 Clinical Trial.
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; European ADHD Guidelines Group. Cortese S, et al. Among authors: dittmann rw. J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. doi: 10.1111/jcpp.12036. Epub 2013 Jan 7. J Child Psychol Psychiatry. 2013. PMID: 23294014 Review.
129 results